Related references
Note: Only part of the references are listed.Dietary emulsifier polysorbate-80-induced small-intestinal vulnerability to indomethacin-induced lesions via dysbiosis
Hirotaka Furuhashi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy
Matteo Fornai et al.
NUTRITION (2020)
The gut microbiome: an orchestrator of xenobiotic metabolism
Stephanie L. Collins et al.
ACTA PHARMACEUTICA SINICA B (2020)
Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation
Emma Hernandez-Sanabria et al.
NPJ BIOFILMS AND MICROBIOMES (2020)
IL-10 produced by macrophages regulates epithelial integrity in the small intestine
Tina L. Morhardt et al.
SCIENTIFIC REPORTS (2019)
Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat
Bernadette Lazar et al.
CELLS (2019)
Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain
Katherine N. Theken et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers
Brynjulf Mortensen et al.
GASTROENTEROLOGY (2019)
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Vayu Maini Rekdal et al.
SCIENCE (2019)
Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii
Yuji Nadatani et al.
SCIENTIFIC REPORTS (2019)
High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17A
Naoki Sugimura et al.
SCIENTIFIC REPORTS (2019)
Gut Microbiota-Mediated Drug-Drug Interaction between Amoxicillin and Aspirin
Juanhong Zhang et al.
SCIENTIFIC REPORTS (2019)
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response
Damian Maseda et al.
MBIO (2019)
Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice
Chaonan Sun et al.
SAUDI PHARMACEUTICAL JOURNAL (2019)
Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae
Michael S. Little et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues
Diego Curro
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Impacts of the Human Gut Microbiome on Therapeutics
Yoshiki Vazquez-Baeza et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Drug-gut microbiota interactions: implications for neuropharmacology
Jacinta Walsh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
NSAIDs and the small bowel
Foong Way David Tai et al.
CURRENT OPINION IN GASTROENTEROLOGY (2018)
Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract
Koji Takeuchi et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota
Shoko Edogawa et al.
FASEB JOURNAL (2018)
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
Ingvar Bjarnason et al.
GASTROENTEROLOGY (2018)
Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics
Ellen M. Wilkinson et al.
MATURITAS (2018)
Indomethacin increases severity of Clostridium difficile infection in mouse model
Juan Munoz-Miralles et al.
FUTURE MICROBIOLOGY (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Effects of none-steroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats
Xi Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding
Moe H. Kyaw et al.
GASTROENTEROLOGY (2018)
Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention
Rocchina Colucci et al.
FRONTIERS IN PHARMACOLOGY (2018)
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial
Ali S. Taha et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling
Kenichi Yoshikawa et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans
Carmelo Scarpignato et al.
GASTROENTEROLOGY (2017)
Microbiome at the Frontier of Personalized Medicine
Purna C. Kashyap et al.
MAYO CLINIC PROCEEDINGS (2017)
Chemical transformation of xenobiotics by the human gut microbiota
Nitzan Koppel et al.
SCIENCE (2017)
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
Rebecca M. Pollet et al.
STRUCTURE (2017)
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Ian D. Wilson et al.
TRANSLATIONAL RESEARCH (2017)
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism
Sook Joung Lee et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus
Elaine Wang Ling Chan et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2017)
Lactobacillus plantarum Strains Can Enhance Human Mucosal and Systemic Immunity and Prevent Non-steroidal Anti-inflammatory Drug Induced Reduction in T Regulatory Cells
Paul de Vos et al.
FRONTIERS IN IMMUNOLOGY (2017)
Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin
Xue Xiao et al.
SCIENTIFIC REPORTS (2017)
The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial
Zlatan Mujagic et al.
SCIENTIFIC REPORTS (2017)
Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
Andrea Ticinesi et al.
SCIENTIFIC REPORTS (2017)
Non-steroidal anti-inflammatory drug-induced enteropathy
Sung Jae Shin et al.
INTESTINAL RESEARCH (2017)
a GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage
Hayakazu Sumida et al.
SCIENCE IMMUNOLOGY (2017)
The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists
Sunil Thomas et al.
CANCER RESEARCH (2017)
Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Takayoshi Suzuki et al.
DIGESTION (2017)
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage
Koji Otani et al.
DIGESTION (2017)
The influence of gut microbiota on drugmetabolismand toxicity
Houkai Li et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy
A. Higashimori et al.
MUCOSAL IMMUNOLOGY (2016)
Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity
Ze-yu Zhong et al.
ACTA PHARMACOLOGICA SINICA (2016)
Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin
In Sook Kim et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective
Carlo Patrono
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden
David C. Montrose et al.
CANCER PREVENTION RESEARCH (2016)
Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial
Ema Washio et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study
N. A. Bokulich et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
The influence of non-steroidal anti-inflammatory drugs on the gut microbiome
M. A. M. Rogers et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
Kazuhiro Ota et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2016)
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Peter Spanogiannopoulos et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic
Matteo Fornai et al.
PHARMACOLOGICAL RESEARCH (2016)
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Alexandra Zhernakova et al.
SCIENCE (2016)
Population-level analysis of gut microbiome variation
Gwen Falony et al.
SCIENCE (2016)
Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
Alberto Lue et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate
Antonella Gallo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis
Nitipong Permpalung et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy
Canaan M. Whitfield-Cargile et al.
GUT MICROBES (2016)
NSAID-Induced Small Intestinal Damage - Roles of Various Pathogenic Factors
Koji Takeuchi et al.
DIGESTION (2015)
How informative is the mouse for human gut microbiota research?
Thi Loan Anh Nguyen et al.
DISEASE MODELS & MECHANISMS (2015)
Antimicrobial activity of ibuprofen: New perspectives on an Old non-antibiotic drug
Jelena Obad et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model
Satoshi Kurata et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2015)
NSAID enteropathy and bacteria: a complicated relationship
Stephanie D. Syer et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model
Yuan-Pin Hung et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Bidirectional interactions between indomethacin and the murine intestinal microbiota
Xue Liang et al.
ELIFE (2015)
Repurposing celecoxib as a topical antimicrobial agent
Shankar Thangamani et al.
FRONTIERS IN MICROBIOLOGY (2015)
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota
Rory W. Blackler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage
Toshio Watanabe et al.
PLOS ONE (2015)
Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin
Yu Lai et al.
PLOS ONE (2015)
Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome
Lian Yee Yip et al.
DRUG METABOLISM AND DISPOSITION (2015)
Incidence and complications of peptic ulcer disease requiring hospitalisation have markedly decreased in Finland
H. Malmi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health
Sridhar Mani et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Gut Dysbiosis Promotes M2 Macrophage Polarization and Allergic Airway Inflammation via Fungi-Induced PGE2
Yun-Gi Kim et al.
CELL HOST & MICROBE (2014)
Prophylactic effects of prostaglandin E2 on NSAID-induced enteropathy - role of EP4 receptors in its protective and healing-promoting effects
Koji Takeuchi
CURRENT OPINION IN PHARMACOLOGY (2014)
Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry
Hiroki Endo et al.
GASTROINTESTINAL ENDOSCOPY (2014)
Peyer's Patches Play a Protective Role in Nonsteroidal Anti-inflammatory Drug-induced Enteropathy in Mice
Satoshi Hiyama et al.
INFLAMMATORY BOWEL DISEASES (2014)
The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium
Osamu Handa et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2014)
Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats
Evangelina Teran-Ventura et al.
JOURNAL OF CROHNS & COLITIS (2014)
A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury
Sei Kurokawa et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Bacterial beta-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
Kyle S. Saitta et al.
XENOBIOTICA (2014)
Shifting the paradigm from pathogens to pathobiome: new concepts in the light of meta-omics
Muriel Vayssier-Taussat et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?
Matteo Fornai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome
Corinne Ferrier Maurice et al.
CELL (2013)
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Wai-Kit Lo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage
Toshio Watanabe et al.
DIGESTIVE AND LIVER DISEASE (2013)
Rebamipide inhibits indomethacin-induced small intestinal injury: Possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5
Tetsuya Tanigawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
NSAID enteropathy: could probiotics prevent it?
Massimo Montalto et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
The gut microbiota - masters of host development and physiology
Felix Sommer et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Bacterial Community Mapping of the Mouse Gastrointestinal Tract
Shenghua Gu et al.
PLOS ONE (2013)
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Henry J. Haiser et al.
SCIENCE (2013)
Multiple NSAID-Induced Hits Injure the Small Intestine: Underlying Mechanisms and Novel Strategies
Urs A. Boelsterli et al.
TOXICOLOGICAL SCIENCES (2013)
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
Carlos Sostres et al.
ARTHRITIS RESEARCH & THERAPY (2013)
High Mobility Group Box 1 Promotes Small Intestinal Damage Induced by Nonsteroidal Anti-Inflammatory Drugs through Toll-Like Receptor 4
Yuji Nadatani et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies
John L. Wallace
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Prostaglandin E2 Suppresses Antifungal Immunity by Inhibiting Interferon Regulatory Factor 4 Function and Interleukin-17 Expression in T Cells
Patricia A. Valdez et al.
IMMUNITY (2012)
Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam
Yuji Maehata et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice
Ying Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice
Lei Diao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice
Amanda LoGuidice et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The changing face of hospitalisation due to gastrointestinal bleeding and perforation
A. Lanas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
Jung-Woo Bae et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
John L. Wallace et al.
GASTROENTEROLOGY (2011)
Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy
Shunji Fujimori et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study
Hiroki Endo et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Aspirin-induced small bowel injuries and the preventive effect of rebamipide
Kazuhiro Mizukami et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study
M. Montalto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs
Yong Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Biotransformation of Flurbiprofen by Cunninghamella Species
Jessica Amadio et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2010)
Biotransformation of Celecoxib Using Microbial Cultures
Keshetty Srisailam et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2010)
The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition
Harri Makivuokko et al.
BRITISH JOURNAL OF NUTRITION (2010)
Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage
Koji Takeuchi et al.
CLINICA CHIMICA ACTA (2010)
Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors
Koji Takeuchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Role of COX-2 in nonsteroidal anti-inflammatory drug enteropathy in rodents
Christoph Hotz-Behofsits et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid
Toshio Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease
Stephen M. Collins et al.
GASTROENTEROLOGY (2009)
Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy
Shunji Fujimori et al.
GASTROINTESTINAL ENDOSCOPY (2009)
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy
Laurence Maiden
JOURNAL OF GASTROENTEROLOGY (2009)
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
T. Andrew Clayton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes
M. Karazniewicz-Lada et al.
XENOBIOTICA (2009)
Small Bowel Injury by Low-Dose Enteric-Coated Aspirin and Treatment With Misoprostol: A Pilot Study
Toshio Watanabe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?
C. Scarpignato
GUT (2008)
The gastrointestinal microbiota as a site for the biotransformation of drugs
Tiago Sousa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study
Yasumasa Niwa et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent
T. Watanabe et al.
GUT (2008)
Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: A cross-sectional capsule enteroscopy study
Laurence Maiden et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Determinants of the short-term gastric damage caused by NSAIDs in man
I. Bjarnason et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Role of bile in pathogenesis of indomethacin-induced enteropathy
Molly Jacob et al.
ARCHIVES OF TOXICOLOGY (2007)
Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road
Mary Treinen-Moslen et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota
Andrew B. Dalby et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori
Haim Shirin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats
Ryo Hatazawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2
S Fries et al.
GASTROENTEROLOGY (2006)
Microbial flora in NSAID-induced intestinal damage: A role for antibiotics?
A Lanas et al.
DIGESTION (2006)
Alterations in the intestinal glycocalyx and bacterial flora in response to oral indomethacin
J Basivireddy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence
DI Tsitsigiannis et al.
INFECTION AND IMMUNITY (2005)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
A quantitative analysis of NSAID-Induced small bowel pathology by capsule enteroscopy
L Maiden et al.
GASTROENTEROLOGY (2005)
Differential expression of COX-1 and COX-2 in the gastrointestinal tract of the rat
R Haworth et al.
TOXICOLOGIC PATHOLOGY (2005)
Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors
R Ohno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Genetically engineered probiotics
L Steidler
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion
M Hervé et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: Relation to various pathogenic events
A Tanaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2
CD Loftin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
G Sigthorsson et al.
GASTROENTEROLOGY (2002)
Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COM-1 and COX-2
AT Blikslager et al.
GUT (2002)
16,16-dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors
T Kunikata et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium
S Annadurai et al.
JOURNAL OF CHEMOTHERAPY (2002)
Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: A key to nonsteroidal anti-inflammatory drug-induced intestinal damage
A Tanaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Production of prostaglandins and leukotrienes by pathogenic fungi
MC Noverr et al.
INFECTION AND IMMUNITY (2002)
Protective effect of rebamipide on indomethacin-induced intestinal damage in rats
H Mizoguchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins
MC Noverr et al.
INFECTION AND IMMUNITY (2001)
Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge
B Gretzer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism
AZA Leite et al.
GUT (2001)
Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans
M Gotteland et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs
A Tanaka et al.
JOURNAL OF PHYSIOLOGY-PARIS (2001)
Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes
T Kunikata et al.
JOURNAL OF PHYSIOLOGY-PARIS (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis
SG Dastidar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
JL Wallace et al.
GASTROENTEROLOGY (2000)
Share Paper
